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Abbreviations: 
TBLH – Total body less head 
BMC – Bone mineral content 
DXA – Dual energy X-ray absorptiometry 
%FM – Whole body percent fat mass  
HOMA-IR – Homeostasis model assessment of insulin resistance 
APHV – Age at peak height velocity 
PA – Physical activity 
MVPA – Moderate to vigorous physical activity 
VPA – Vigorous physical activity 
 
Highlights  
 Insulin resistance was inversely associated with bone mass in adolescent boys 
 The association in boys was not explained by differences in body composition or physical activity levels 
 No association between insulin resistance and bone mass was observed in adolescent girls. 
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Abstract: 
Purpose: Insulin resistance may exert a negative influence on bone mass in childhood and 
adolescence. The objective was to assess the association between insulin resistance and total body 
less head (TBLH) bone mineral content (BMC) and to investigate whether body composition, 
physical activity or osteocalcin levels may influence this association. 
Methods: A longitudinal study with follow-up over more than 6 years was performed and included 
562 apparently healthy participants with a mean age of 9.6 years at baseline. 
Participants underwent DXA scanning at baseline. At the two follow-ups, participants had 
performed another DXA scanning, had blood samples taken for fasting insulin, glucose and 
osteocalcin and had physical activity measured with an accelerometer. HOMA-IR was calculated as 
an index of insulin resistance. 
Results: HOMA-IR was negatively associated with TBLH BMC in boys at follow-ups (β = -31.4, p 
<0.001) after adjustment for maturity, height, bone area, and baseline level of TBLH BMC. The 
negative association remained almost unchanged after further adjustments for body composition 
and physical activity. No association between HOMA-IR and TBLH BMC was found in girls.  
Conclusion: Insulin resistance may be detrimental for bone development through puberty in boys 
independent of body composition and the level of physical activity. 
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1. Introduction 
Bone mass increases during childhood and adolescence until peak bone mass is reached [1]. As the 
risk of osteoporosis later in life may be reduced by increasing peak bone mass [1, 2], it is important 
to identify factors that influence peak bone mass. 
Insulin itself may have osteogenic effects [3], and cross-sectional studies report a positive 
association between bone mass and fasting insulin in different age groups [4-6]. However, this 
association disappears or changes direction after adjustment for body composition. In line with this 
data Torres-Costoso et al. [7] suggested an influence from body composition on the association 
between insulin resistance and bone mass. Body composition is known to be associated with bone 
mass level in childhood and adolescence, where lean mass may contribute more to the variance in 
bone mass than fat mass [8, 9].  
The association between bone mass and fasting insulin or insulin resistance (as expressed by the 
homeostasis model assessment of insulin resistance, HOMA-IR) may be sex-specific as suggested 
in some cross-sectional studies [5, 10, 11]. Studies with longitudinal data in children are few, but 
Dalskov et al [12] found no association between insulin and bone mass over a time period of six 
months. 
Physical activity (PA) is known to be positively associated with bone mass in childhood and 
adolescence [13] and may also alter insulin resistance in children [14, 15]. However, a potential 
interaction between insulin resistance and PA on bone mass has not been fully elucidated. 
Osteocalcin (OC) is a bone specific non-collagen protein synthesised by osteoblasts and is a 
sensitive marker of bone formation [16]. After synthesis, OC is carboxylated and then mainly 
incorporated into bone matrix. OC is also thought to play a role in glucose metabolism [17, 18] and 
may act as a hormone to increase insulin sensitivity [19]. The evidence for an association between 
OC and glucose metabolism in children is sparse, however; and Giudici et al. [20] did not observe 
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an association between osteocalcin and HOMA-IR in healthy children. The exact mechanisms of 
OC functions are unclear, but it is thought to be the undercarboxylated OC (ucOC) that represents 
the active part acting as a hormone [18, 21]. Both fully carboxylated OC and ucOC are measurable 
in the circulation, and no clear conclusions can be made. 
The objectives of the present study were 1) to examine the association between insulin resistance 
and bone mass in healthy children and adolescents, and 2) to investigate whether body composition, 
physical activity or osteocalcin may influence such an association. 
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2. Methods 
2.1. Ethical considerations 
Children and parents received written information prior to study start as well as verbal information 
at school meetings. Written informed consent was provided by parents before entering the study. 
Participation was voluntary for all children, and consent could be withdrawn at any time. The 
CHAMPS-study DK was approved by the Regional Scientific Ethical Committee of Southern 
Denmark (Project ID:S2008-0047, S-20140105). The study was accepted by the Danish Data 
Protection Agency. 
2.2. Study design and participants 
The Childhood Health Activity and Motor Performance School Study, Denmark (CHAMPS-study 
DK) is a longitudinal school-based observational study conducted from 2008 to 2015, described in 
detail elsewhere [22]. Children aged 6-11 years at baseline from 10 public schools in the Danish 
municipality of Svendborg were invited to participate. The present sub-study included the oldest 
part of the cohort attending 2
nd
 – 4th grade at baseline (7.7-12.0 years old). Participants with 
diabetes or bone disease were excluded from this sub-study. Participants with at least one follow-up 
examination (2-years follow-up and the last follow-up after more than 6 years) in addition to the 
baseline examination were included in statistical analyses.  
2.3. Dual energy X-ray absorptiometry 
Dual energy X-ray absorptiometry (DXA) scans were performed at three time-points 
(autumn/winter 2008/2009, autumn winter 2010/2011 and spring 2015) using a GE Lunar Prodigy 
with enCORE software (version 15; GE Medical Systems, Madison, WI, USA). All scans were 
conducted using the same DXA scanner at Hans Christian Andersen Children’s Hospital, Odense 
University Hospital, Denmark, with three operators performing all scans and two operators (MH 
and MSR) analysing all data. 
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Participants were scanned in a supine position wearing undergarments, stockings and a thin T-shirt 
and lying under a thin blanket. The scan depth was automatically altered according to age, height 
and weight of the child. The scanner had a height limit of 195 cm, and participants taller than this 
limit were excluded before DXA scanning. 
The scanner was tested for reproducibility and precision every morning using a standard phantom in 
accordance with the recommendations from the manufacturer. The scanner had a coefficient of 
variation (CV%) for the phantom areal bone mineral density (aBMD) of 0.27 – 0.33% during the 
whole study period. 
Total body less head (TBLH) values were used to obtain bone mineral content (BMC) and bone 
area. Also whole body percent fat mass (%FM) was obtained by the DXA scan and used in 
combination with weight as a measure for body composition. 
2.4. Anthropometry and maturational development 
Before the DXA scan, participants had height and weight measured. Height was measured with a 
portable stadiometer to the nearest 0.1 cm (SECA 213), and weight was measured to the nearest 0.1 
kg on an electronic scale (SECA 861) (Both SECA gmbh & co. kg, Hamburg, Germany). 
Maturational status (maturity) was defined as number of years from age at peak height velocity 
(APHV) at the examination. Maturity was calculated based on the child’s age and height according 
to the equations described by Moore et al. [23]. The height measurement performed nearest to the 
time for APHV for that child was used. 
2.4.1. WHO Z-scores 
Body mass index (BMI; defined as “weight in kg / height in m squared”) was calculated and used to 
further calculate age- and sex-adjusted World Health Organisation (WHO) reference Z-scores for 
BMI using a software package from WHO [24]. These Z-scores were used to define overweight 
(WHO-BMI-Z-score > 1) and obesity (WHO-BMI-Z-score > 2) [25].  
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2.5. Laboratory analyses 
Blood samples were obtained at the participants schools following an overnight fast (at least 8 hours 
was requested). Fasting status was verbally confirmed by the child. The samples were taken 
between 08.00 and 10.00 a.m. by trained biomedical laboratory technicians and were processed and 
centrally stored at -80°C within 4 hours. 
Samples were analysed for glucose and insulin in an ISO 9001:2008 certified routine laboratory 
associated with the University of Vienna, Austria. Glucose levels were assessed on a Cobas C 
System (Roche Diagnostics GmbH, Mannheim, Germany), while insulin levels were assessed on an 
Access Immunoassay System (Beckman Coulter, Inc. Brea, CA, USA) using the respective kits.  
Osteocalcin measurements were performed on the IDS-iSYS automated system using the 
chemiluminescence immunoassay IDS-iSYS N-MID
®
Osteocalcin (Immunodiagnostic Systems, 
Tyne & Wear, UK) at the Department of Clinical Biochemistry, Glostrup, Rigshospitalet, Denmark, 
which is ISO 15189 certified. 
Intermediate precision (CV%) ranged from 0.5 to 0.8 % for glucose, from 3.1 to 5.6 % for insulin 
and from 3.0% to 3.6% for osteocalcin. 
HOMA-IR [26] was calculated as (fasting insulin in μIU/ml * fasting glucose in mmol/l / 22.5) and 
was used as a surrogate marker of insulin resistance.  
2.6. Physical activity 
PA was assessed objectively by GT3X and GT3X+ accelerometers (ActiGraph, Pensacola, Florida, 
USA). Measurements were performed in autumn 2010 and spring 2015. 
Accelerometers were programmed to start recording the day after distribution and were collected 
after at least 7 days of wear. Participants were asked to wear the device on the right hip during all 
waking hours and to remove it only for water-based activities. All consecutive strings of zero counts 
spanning 30 minutes or more were interpreted as “accelerometer not worn”, and these strings were 
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deleted from the data. The accelerometers stored data every 2 seconds (GT3X) and in 30Hz 
(GT3X+). Recordings were collapsed into a 10-second epoch for analyses according to previous 
studies from the CHAMPS-study DK [27, 28]. Participants with a minimum of 3 days recording 
with at least 10 hours valid recording per day were included in the analyses. The data output were 
analysed using customized software (Propero version 1.7.4, University of Southern Denmark, 
Odense, Denmark). Accelerometer recordings were coded as moderate to vigorous physical activity 
(MVPA; ≥ 2296 counts per minute) or vigorous physical activity (VPA; ≥ 4012 counts per minute) 
according to Evenson et al. [29, 30]. The percentage of wear-time spent engaging in MVPA and 
VPA was used in the analyses. 
2.7. Statistical analyses 
All statistical analyses were performed using STATA/IC 14.2 (StataCorp Lp, College Station, TX, 
USA). P values less than 0.05 were considered statistically significant. 
Differences between sexes were tested with unpaired t-tests. 
2.7.1. Linear mixed-effect models 
Linear mixed-effect models were used to analyse factors associated with TBLH BMC at the follow-
ups. As a high degree of collinearity was found between age and maturity, only maturity was used 
in the models. 
The basic model (model 1) was adjusted for baseline level of TBLH BMC and for sex, maturity, 
size (height and bone area) and the independent variable of interest (HOMA-IR) at follow-up. 
An interaction term between HOMA-IR and sex was afterwards added to the model and if this was 
statistically significant, the analyses were stratified by sex. As %FM may also influence BMC 
differently in boys and girls, a sex-by-%FM interaction term was included in the models adjusting 
for body composition. The interaction term was omitted if non-significant. 
The models incorporated school classes and participant identification as random effects. 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
10 
 
After fitting the basic model, new models were built that included additional explanatory variables 
of body composition (weight and %FM), MVPA, VPA and OC. 
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3. Results 
3.1. Participant characteristics  
A total of 562 participants (277 boys) were included, with 1256 DXA scans (562 at baseline, 535 at 
2-year follow-up, and 159 at the last follow-up; 132 participants had all 3 measurements) and 
follow-up data on fasting HOMA-IR (Fig. 1). A further 33 participants had missing PA data and 
were excluded from models adjusting for PA. 
Mean age at baseline was 9.6 years (range 7.7 to 12.0 years), and 83.6% of baseline BMI 
measurements were within normal limits for BMI according to the WHO definition (16.4% were 
overweight, and of these 3.4% were obese).  
At follow-ups, fasting glucose ranged from 3.5 to 6.4 mmol/l and fasting insulin from 0.9 to 23.41 
μIU/ml (interquartile range for fasting insulin: 3.3 to 6.6 μIU/ml). 
Further characteristics are presented in Table 1. 
3.2. Associations with TBLH BMC 
HOMA-IR was inversely associated with TBLH BMC in children aged 10-17 years at follow-ups 
after adjustment for maturity, sex, size (height and bone area) and baseline TBLH BMC (β = -21.8, 
p < 0.001)(Table 2). A significant interaction between HOMA-IR and sex was found (βHOMA-by-girl = 
27.2, p < 0.05), and further analyses were stratified by sex.  
The sex difference was confirmed in the stratified analyses, where an inverse association between 
HOMA-IR and TBLH BMC was found in boys (β = -31.4, p < 0.001), but no association was found 
in girls in any of the models (Table 3). 
Additional adjustment for body composition (weight and %FM), MVPA, VPA or OC yielded only 
minor changes in the magnitude of the association between HOMA-IR and TBLH BMC in boys 
(Table 3). 
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Figure 2 shows the sex differences in TBLH BMC dependence on HOMA-IR and the amount of 
time spent engaging in VPA. 
MVPA and VPA were positively associated with TBLH BMC in both sexes, showing no interaction 
with HOMA-IR. Body composition (weight and %FM) also showed significant associations with 
TBLH BMC in the same directions for boys and girls. While %FM was negatively associated with 
TBLH BMC, weight was positively associated with TBLH BMC.  
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4. Discussion 
We found a highly significant inverse association between TBLH BMC and HOMA-IR in boys, 
whereby boys with higher HOMA-IR had on average lower TBLH BMC. The association was 
virtually unchanged after further adjustment for body composition, physical activity or osteocalcin. 
No association between HOMA-IR and TBLH BMC was observed in girls, suggesting that insulin 
resistance influences bone mass in a sex-dependent manner in children aged 10-17 years. 
 
Our findings are thus in line with results from previous cross-sectional studies [5, 10, 11] that found 
similar sex differences in the association between HOMA-IR and bone mass. The participants in 
this study were apparently healthy children and adolescents without diabetes, and thus a higher 
HOMA-IR will mainly be driven by higher insulin levels as the range of glucose levels was 
relatively narrow. With increasing insulin resistance, the tissues become less sensitive to insulin and 
the anabolic effects from insulin diminish. This may partly explain the negative association between 
HOMA-IR and TBLH BMC in adolescent children.  
We are unable to explain the sexually dimorphic associations. However, it can be speculated 
whether the differences in sex-hormones between boys and girls may influence the negative 
association observed between bone mass and insulin resistance in boys [5]. Body composition was 
described by weight and %FM, and both of these were significantly associated with TBLH BMC in 
the same direction for boys and girls (Table 3), although sex differences in body composition 
increase during puberty [31]. Body composition may influence the association between HOMA-IR 
and bone mass as suggested by some authors [6, 7], but this was not evident in our study. The 
association between HOMA-IR and TBLH BMC was only slightly affected by the addition of body 
composition to the models. It can, however, be speculated if sex-differences in body fat distribution 
may play a role [11]. 
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Further studies are though needed to clarify whether some of these sex-differences can be explained 
by differences in visceral-fat distribution or differences in hormones. 
Physical activity was measured objectively for at least 3 days at follow-ups with accelerometers and 
assumed to be representative of the physical activity level of the participants. MVPA or VPA levels 
did not influence the association between HOMA-IR and TBLH BMC in boys. This is in line with 
the result from Lawlor et al. [32] who in a cross-sectional study showed that MVPA did not alter 
associations between fasting insulin and bone mass in adolescents aged 15-16 years. Insulin 
resistance generally increases during puberty [33], and children may also tend to be less active in 
later puberty, as found by Janz et al. [34] and our study (Table 1). Children and adolescents may be 
able to improve their insulin resistance by increasing the amount of time engaging in VPA [14, 35] 
and, based on the observed associations, thereby potentially reduce some of the negative effects on 
bone mass. On the other hand, increasing the time spent engaging in VPA may also increase bone 
mass independently of HOMA-IR level. A greater amount of VPA may thus be able to counteract 
some of the observed negative association from HOMA-IR on TBLH BMC in adolescents, 
although no direct interaction was found. Further research is needed to clarify this. 
No interaction between OC and HOMA-IR with TBLH BMC was found in this study, and OC did 
not influence the negative association between HOMA-IR and TBLH BMC in boys. OC was 
negatively associated with TBLH BMC in line with Erceg et al. [36], whereas other studies have 
reported diverse results from no association between OC with bone mass [37] to a positive 
association between OC and BMC [12, 38]. The exact role of OC in glucose metabolism and bone 
remodelling in humans, and especially children, still remains to be elucidated [21]. 
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Strengths and limitations: 
Strengths of this study include the long follow-up time spanning more than 6 years as well as the 
inclusion of objectively measured physical activity and the hormone osteocalcin in analyses. The 
study had a large sample size with a total of 562 participants and 1256 DXA scans conducted on the 
same DXA device over the study period. All participants were apparently healthy, which increases 
our ability to generalise to the general youth population, although the low prevalence of obesity in 
the sample may require replication studies in populations with more obesity. Furthermore, although 
accelerometers may be superior to subjective measures in measuring physical activity [39], they are 
not able to measure water-based activities or activity of the upper body which may have altered the 
results. 
Key limitations include a high drop-out rate before the last follow-up. Additionally, HOMA-IR was 
used as a surrogate measure of insulin resistance instead of a directly measure of insulin resistance. 
However, this method has proved to be a robust tool in epidemiological studies [26]. Total OC was 
used in analyses, as we were unable to measure ucOC that is thought to be the active part of 
osteocalcin in humans [18]. Other limitations are that calcium and vitamin D intake were not 
assessed, and that physical activity level was measured with accelerometers in 2010 and 2015 but 
not at baseline in 2008. The accelerometers do not provide an exact measure of physical activity at 
the individual-level but arguably provides the optimal balance between validity and feasibility 
available for epidemiological studies. We investigated the relationship between follow-up TBLH 
BMC and follow-up HOMA-IR, so our analyses do not provide a longitudinal interpretation of the 
exposure-outcome relation. However, the risk of reverse causality bias is reduced by controlling for 
baseline TBLH BMC. 
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5. Conclusions 
A highly significant negative association was found between HOMA-IR and bone mass in boys, 
whereas no association was found in girls. The negative association in boys was not altered by body 
composition or physical activity, meaning that HOMA-IR might influence bone mass in a sex-
dependent manner in children and adolescents independently of body composition or physical 
activity. Further studies are needed to better understand these sex differences. 
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Figure 1 Participant inclusion 
Flowchart of the inclusion of participants 
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Table 1 Participant characteristics 
Key variables 
 2008* 
boys n=277, girls n=285 
2010* 
boys n=265, girls n=270 
2015* 
boys n=81, girls n=78 
  mean (SD) p-value** mean (SD) p-value** mean (SD) p-value** 
        
Age (years) 
boys 9.6 (0.9) 
0.50 
11.5 (0.9) 
0.78 
15.5 (0.7) 
0.76 
girls 9.6 (0.9) 11.5 (0.9) 15.5 (0.8) 
        
Height (cm) 
boys 140.3 (7.8) 
0.003 
151.4 (9.0) 
0.62 
176.3 (7.8) 
< 0.001 
girls 138.4 (7.1) 151.1 (8.2) 167.3 (5.9) 
        
Weight (kg) 
boys 33.0 (6.6) 
0.13 
40.8 (9.0) 
0.90 
61.5 (9.8) 
0.005 
girls 32.2 (6.1) 40.9 (8.3) 57.5 (8.3) 
        
BMI (kg/m
2
) 
boys 16.6 (2.2) 
0.77 
17.6 (2.5) 
0.50 
19.7 (2.1) 
0.03 
girls 16.7 (2.1) 17.8 (2.5) 20.5 (2.5) 
        
BMC (g) 
boys 890.8 (193.5) 
0.004 
1192.9 (286.7) 
0.97 
2190.1 (423.3) 
< 0.001 
girls 843.4 (197.1) 1193.8 (304.5) 1945.5 (345.3) 
        
aBMD 
(g/cm
2
) 
boys 0.77 (0.05) 
0.05 
0.84 (0.07) 
0.51 
1.05 (0.10) 
0.002 
girls 0.76 (0.06) 0.84 (0.08) 1.01 (0.08) 
        
BA (cm
2
) 
boys 1151.7 (177.4) 
0.001 
1409.7 (233.2) 
0.62 
2068.2 (254.4) 
< 0.001 
girls 1102.4 (174.8) 1399.7 (232.2) 1920.3 (218.0) 
        
HOMA-IR 
boys 0.8 (0.4) 
0.003 
1.0 (0.5) 
< 0.001 
1.3 (0.8) 
0.037 
girls 0.9 (0.7) 1.2 (0.6) 1.5 (0.7) 
        
OC (μg/l) 
boys 122.4 (34.7) 
< 0.001 
152.9 (49.7) 
< 0.001 
152.2 (62.6) 
< 0.001 
girls 144.6 (41.9) 174.4 (47.5) 74.5 (48.1) 
        
%FM
 boys 17.5 (7.6) 
< 0.001 
19.4 (8.0) 
< 0.001 
13.1 (6.4) 
< 0.001 
girls 23.2 (7.3) 24.5 (7.0) 27.3 (6.5) 
        
Years from 
PHV 
boys -3.7 (0.9) 
< 0.001 
-1.8 (0.9) 
< 0.001 
2.1 (0.8) 
< 0.001 
girls -2.3 (0.9) -0.3 (0.9) 3.6 (0.8) 
 
Physical 
Activity 
  2010 
boys n= 238, girls n=261 
2015 
boys n=70, girls n=73 
       
Days included  
boys  5.9 (1.2)  
0.44 
6.5 (1.8) 
0.95 
girls  6.0 (1.2) 6.5 (2.0) 
       
Hours pr. day 
boys  13.6 (0.8) 
0.76 
14.1 (0.9) 
0.94 
girls  13.6 (0.8) 14.1 (0.9) 
       
MVPA (%) 
boys 9.4 (3.1) 
< 0.001 
6.8 (2.6) 
0.001 
girls 6.7 (2.0) 5.5 (2.1) 
      
VPA (%) 
boys 3.7 (1.7) 
< 0.001 
3.1 (1.6) 
< 0.001 
girls 2.5 (1.1) 2.2 (1.4) 
*2008: autumn/winter 2008-2009, 2010: autumn/winter 2010-2011, 2015: spring 2015 
** Differences between sexes were tested with unpaired t-test. 
 
Abbreviations: SD, Standard deviation; BMI, body mass index (weight/height2); BMC, total body less head bone mineral content; 
aBMD, total body less head areal bone mineral density; BA, total body less head bone area; HOMA-IR, homeostasis model 
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assessment of insulin resistance; OC, Osteocalcin (μg/l); %FM, whole body percent fat mass; PHV, peak height velocity; Days 
included, number of days with valid accelerometer data; Hours pr. day, hours per day with valid accelerometer data; MVPA, % time 
spent engaging in moderate to vigorous physical activity; VPA, % time spent engaging in vigorous physical activity. 
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Table 2 Associations between TBLH BMC and HOMA-IR 
TBLH BMC 
Model 1 
 
Model 1b Model 2 Model 3 
 β 
 
β β β 
Baseline TBLH BMC (g) -0.003  0.004 0.05# 0.0005 
Bone area (cm2) 1.6†  1.6† 1.3† 1.5† 
Height (cm) -9.4†  -9.6† -11.5† -9.6† 
Maturityboy (years) 47.2
†  51.3† 36.3† 52.3† 
Girl -61.9†  -97.6† -32.0 -93.2† 
Girl-by-maturity -21.7†  -25.3† -11.1‡ -25.5† 
HOMA-IRboth sexes -21.8
†     
HOMA-IRboy  -35.2
† -28.1† -32.5† 
Girl-by-HOMA-IR  27.2# 25.9‡ 29.3‡ 
Weight (kg)   10.4†  
%FM   -7.7†  
VPA    8.2† 
†significant at p < 0.001; ‡ significant at p < 0.01; # significant at p < 0.05 
Sex interactions calculated with boys as reference 
Number of participants (number of follow-up scans): model 1+2: n = 562 (694 DXA), model 3: n = 529 (642 DXA) 
 
Model 1=Adjusted for sex, maturity, size (height and bone area) and baseline TBLH BMC level; Model 1b=Adjusted for sex, 
maturity, size (height and bone area), baseline TBLH BMC level, and including an interaction term between HOMA-IR and sex; 
Model 2=Model 1b + body composition (weight and %FM), Model 3=Model 1b + VPA 
 
Abbreviations: TBLH BMC, total body less head bone mineral content; Bone area, total body less head bone area; Maturity, years 
from age at peak height velocity; Girl-by-maturity, interaction term between being a girl and maturity; HOMA-IR, homeostasis 
model assessment of insulin resistance; Girl-by-HOMA-IR, interaction term between being a girl and HOMA-IR; %FM, whole body 
percent fat mass; VPA, % time spent engaging in vigorous physical activity 
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Table 3 Associations between TBLH BMC and HOMA-IR stratified by sex: 
TBLH BMC 
Boys 
Model 1  Model 2 Model 3 Model 3b Model 4 Model 5 
 
 β  β  β  β  β β 
 
Baseline TBLH BMC (g) -0.14† -0.04 -0.16† -0.16† -0.07# -0.13† 
Bone area (cm2) 1.7† 1.3† 1.7† 1.7† 1.3† 1.7† 
Height (cm) -10.3† -10.9† -10.2† -10.2† -10.5† -9.1† 
Maturity (years) 35.3† 20.4‡ 35.6† 37.8† 21.7‡ 31.5† 
HOMA-IR -31.4
† -28.9† -27.1‡ -29.1‡ -30.2‡ -29.3† 
Weight (kg)  12.4†   11.6†  
%FM  -8.3†   -7.3†  
VPA   10.2‡  5.8*  
MVPA    4.5‡   
OC (μg/l)      -0.32† 
TBLH BMC 
Girls 
Model 1 Model 2 Model 3  Model 3b  Model 4  Model 5 
 β  β  β  β  β β 
 
Baseline TBLH BMC (g) 0.18† 0.17† 0.18† 0.19† 0.16† 0.18† 
Bone area (cm2) 1.4† 1.3† 1.4† 1.4† 1.3† 1.4† 
Height (cm) -9.5† -11.7† -9.6† -9.5† -11.6† -8.5† 
Maturity (years) 44.0† 40.0† 45.3† 46.2† 40.3† 36.4† 
HOMA-IR -2.9 2.4 1.9 1.3 4.2 -1.5 
Weight (kg)  7.4†   7.1†  
%FM  -6.0†   -5.4†  
VPA   8.4‡  5.3*  
MVPA    3.6#   
OC (μg/l)      -0.19# 
†significant at p < 0.001; ‡ significant at p < 0.01; # significant at p < 0.05 
* p-values for VPA in model 4: Boys p=0.051, Girls p= 0.070 
Number of participants (number of follow-up scans): Boys: Model 1+2: n = 277 (346 DXA), model 3+4: n = 250 (308 DXA), model 
5: n = 275 (340 DXA); Girls: Model 1+2: n = 285 (348 DXA), model 3+4: n = 279 (334 DXA), model 5: n = 282 (342 DXA) 
 
Model 1=Adjusted for maturity, size (height and bone area) and baseline TBLH BMC level; Model 2=Model 1 + body composition 
(weight and %FM); Model 3=Model 1 + VPA; Model 3b= Model 1 + MVPA; Model 4=Model 1 + VPA + body composition; Model 
5= Model 1 + OC  
 
Abbreviations: TBLH BMC, total body less head bone mineral content; Bone area, total body less head bone area; Maturity, years 
from age at peak height velocity; HOMA-IR, homeostasis model assessment of insulin resistance; %FM, whole body percent fat 
mass; VPA, % time spent engaging in vigorous physical activity; MVPA, % time spent engaging in moderate to vigorous physical 
activity; OC, osteocalcin (μg/l) 
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Figure 2 Predicted values of TBLH BMC dependence on HOMA-IR and percent time spent engaging 
in vigorous physical activity (VPA) 
Further adjusted for baseline TBLH BMC, bone area, height and sex 
Solid lines represent girls and dotted lines represent boys 
 
 
Abbreviations: TBLH BMC, total body less head bone mineral content; HOMA-IR, homeostasis model assessment of insulin 
resistance 
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